Diego
Martínez Urbistondo
Colaborador Médico
Harvard University
Cambridge, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard University (6)
2023
-
Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
Biomedicine and Pharmacotherapy, Vol. 161
-
Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)
Frontiers in Endocrinology
-
Dietary Iron, Anemia Markers, Cognition, and Quality of Life in Older Community-Dwelling Subjects at High Cardiovascular Risk
Nutrients, Vol. 15, Núm. 20
-
Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset
European Journal of Clinical Investigation, Vol. 53, Núm. 10
2022
-
Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis
Frontiers in Endocrinology, Vol. 13
-
Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort
Frontiers in Endocrinology, Vol. 13